Particle.news

Download on the App Store

Lupin to Build $250 Million Respiratory Drug Plant in Coral Springs, Florida

The site aims to bolster U.S. medicine security by domesticating production of more than 25 inhalation treatments.

Overview

  • The Indian drugmaker said it will invest $250 million over five years covering research and development, infrastructure and capital expenditures.
  • The Coral Springs facility is designed to produce more than 25 respiratory medicines, including albuterol inhalers for children with asthma and U.S. service members.
  • Lupin acquired more than five acres for a roughly 70,000-square-foot expansion, with construction projected to employ over 1,000 workers, according to local reporting.
  • The project is expected to create over 200 long-term skilled jobs in Broward County by 2030, with Florida pledging tax credits and other incentives for the investment.
  • Shares rose about 3% in early trading on Indian exchanges following the announcement, reflecting a positive investor reaction.